Company Filing History:
Years Active: 2014-2024
Title: Debashis Mitra: Innovator in Antiviral Drug Development
Introduction
Debashis Mitra is a prominent inventor based in Maharashtra, India. He has made significant contributions to the field of antiviral drug development, particularly in the fight against HIV. With a focus on innovative pharmaceutical compositions, Mitra has been instrumental in advancing research that could lead to effective treatments.
Latest Patents
Mitra holds 2 patents that showcase his groundbreaking work. His latest patents include the development of antiviral drug compounds and compositions. This invention relates to compounds and pharmaceutical compositions that exhibit antiviral effects. Over 1200 molecules were screened, leading to the identification of 55 molecules with statistically significant anti-HIV activity. Among these, the compound Methotrexate (MTX-HYD) and its analogues were selected for repurposing as anti-HIV drugs. Additionally, he has developed a pharmaceutical composition that possesses virucidal and spermicidal activity. Acaciaside-B (Ac-B) has emerged as a promising candidate for preventing HIV infection and has potential applications as a vaginal contraceptive. Ac-B demonstrates anti-HIV properties at low concentrations, is non-mutagenic, and does not harm the vaginal niche, making it a superior ingredient for formulations aimed at creating a chemical barrier against HIV-1 infection.
Career Highlights
Throughout his career, Debashis Mitra has worked with esteemed organizations such as the National Centre for Cell Science and the Council of Scientific & Industrial Research. His work in these institutions has allowed him to contribute significantly to scientific research and innovation in the field of virology.
Collaborations
Mitra has collaborated with notable colleagues, including Jay Trivedi and Syed Nazrul Kabir. These collaborations have further enriched his research and development efforts in antiviral drug discovery.
Conclusion
Debashis Mitra's innovative work in antiviral drug development highlights his commitment to addressing critical health challenges. His contributions have the potential to make a significant impact in the fight against HIV, showcasing the importance of research and innovation in the pharmaceutical industry.